You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 4, April 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  News and Views
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (216)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal

Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical Trials

An Analysis of the Food and Drug Administration Database

Arif Khan, MD; Heather A. Warner, MA; Walter A. Brown, MD

Arch Gen Psychiatry. 2000;57:311-317.

The assumption that depressed patients who are assigned to placebo in antidepressant clinical trials are exposed to substantial morbidity and mortality is not based on research data. We assessed suicides, suicide attempts, and depressive symptom reduction in studies of 7 new antidepressants using the Food and Drug Administration database. Among 19 639 participating patients, 34 committed suicide (0.8% per year), and 130 attempted suicide (2.9% per year). Rates of suicide and attempted suicide did not differ significantly among the placebo- and drug-treated groups. Annual rates of suicide and attempted suicide were 0.4% and 2.7% with placebo, 0.7% and 3.4% with active comparators, and 0.8% and 2.8% with investigational antidepressants, respectively. Symptom reduction was 40.7% with investigational drugs (n=4510), 41.7% with active comparators (n=1416), and 30.9% with placebo (n=2805). These data may help inform discussions about the use of placebo in antidepressant clinical trials.


From the Northwest Clinical Research Center, Bellevue, Wash (Dr Khan and Ms Warner); and the Department of Psychiatry, Brown University, Providence, RI (Dr Brown).


RELATED ARTICLES

Placebo Controls: No News Is Good News
Paul Leber
Arch Gen Psychiatry. 2000;57(4):319-320.
EXTRACT | FULL TEXT  

The Placebo Problem Remains
Karin B. Michels
Arch Gen Psychiatry. 2000;57(4):321-322.
EXTRACT | FULL TEXT  

What Conditions Are Necessary to Assess Antidepressant Efficacy?
Frederic M. Quitkin and Donald F. Klein
Arch Gen Psychiatry. 2000;57(4):323-324.
EXTRACT | FULL TEXT  

Suicide and Antidepressant Treatment
Robert M. A. Hirschfeld
Arch Gen Psychiatry. 2000;57(4):325-326.
EXTRACT | FULL TEXT  

Statistical Analysis to Settle Ethical Issues?
Helena Chmura Kraemer
Arch Gen Psychiatry. 2000;57(4):327-328.
EXTRACT | FULL TEXT  

Placebo Protects Subjects From Nonresponse: A Paradox of Power
Andrew C. Leon
Arch Gen Psychiatry. 2000;57(4):329-330.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sadness, Depression, and Avoidance Behavior
Leventhal
Behav Modif 2008;32:759-779.
ABSTRACT  

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials
Barbui et al.
CMAJ 2008;178:296-305.
ABSTRACT | FULL TEXT  

An effect-size analysis of pharmacologic treatments for generalized anxiety disorder
Hidalgo et al.
J Psychopharmacol 2007;21:864-872.
ABSTRACT  

An Intensive Treatment Program of Interpersonal Psychotherapy Plus Pharmacotherapy for Depressed Inpatients: Acute and Long-Term Results
Schramm et al.
Am. J. Psychiatry 2007;164:768-777.
ABSTRACT | FULL TEXT  

Placebo Response and Antidepressant Response
Alexopoulos et al.
AJGP 2007;15:149-158.
ABSTRACT | FULL TEXT  

The diagnosis and management of depression and anxiety in primary care: the need for a different framework
Jacob
Postgrad. Med. J. 2006;82:836-839.
FULL TEXT  

The antidepressant tale: figures signifying nothing?
Healy
Adv. Psychiatr. Treat. 2006;12:320-327.
ABSTRACT | FULL TEXT  

Did regulators fail over selective serotonin reuptake inhibitors?
Healy
BMJ 2006;333:92-95.
FULL TEXT  

Ethical issues in psychopharmacology.
McHenry
J. Med. Ethics 2006;32:405-410.
ABSTRACT | FULL TEXT  

Bias in Clinical Intervention Research
Gluud
Am J Epidemiol 2006;163:493-501.
ABSTRACT | FULL TEXT  

Suicidality in pediatric patients treated with antidepressant drugs.
Hammad et al.
Arch Gen Psychiatry 2006;63:332-339.
ABSTRACT | FULL TEXT  

The Relevance of Empirical Research in Bioethics
Miller and Wendler
Schizophr Bull 2006;32:37-41.
ABSTRACT | FULL TEXT  

Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain
Dworkin et al.
Neurology 2005;65:S7-S19.
ABSTRACT | FULL TEXT  

Ethical aspects of placebo groups in pain trials: Lessons from psychiatry
Nagasako and Kalauokalani
Neurology 2005;65:S59-S65.
ABSTRACT | FULL TEXT  

Neurobiological Mechanisms of the Placebo Effect
Benedetti et al.
J. Neurosci. 2005;25:10390-10402.
FULL TEXT  

Efficacy of antidepressants in adults
Moncrieff and Kirsch
BMJ 2005;331:155-157.
FULL TEXT  

When Health Policy Is the Problem: A Report from the Field
Spitz and Abramson
Journal of Health Politics, Policy and Law 2005;30:327-366.
ABSTRACT  

Do selective serotonin reuptake inhibitors cause suicide?: Let's keep it in perspective
Sakinofsky and Streiner
BMJ 2005;330:1149-1149.
FULL TEXT  

Suicide Risk in Placebo-Controlled Trials of Treatment for Acute Manic Episode and Prevention of Manic-Depressive Episode
Storosum et al.
Am. J. Psychiatry 2005;162:799-802.
ABSTRACT | FULL TEXT  

St John's wort for depression: Meta-analysis of randomised controlled trials
LINDE et al.
Br. J. Psychiatry 2005;186:99-107.
ABSTRACT | FULL TEXT  

Depression: An Update for the Clinician
Nierenberg et al.
Focus 2005;3:3-12.
FULL TEXT  

Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders
Jindal and Thase
Focus 2005;3:114-121.
ABSTRACT | FULL TEXT  

Research Design Features and Patient Characteristics Associated With the Outcome of Antidepressant Clinical Trials
Khan et al.
Am. J. Psychiatry 2004;161:2045-2049.
ABSTRACT | FULL TEXT  

Antidepressants and public health in Iceland: Time series analysis of national data
Helgason et al.
Br. J. Psychiatry 2004;184:157-162.
ABSTRACT | FULL TEXT  

Conflicts of Interest in Biomedical Research Harm Children With and Without Disabilities
Sharav
Journal of Disability Policy Studies 2004;15:50-59.
ABSTRACT  

Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors
Nutt
J Psychopharmacol 2003;17:355-364.
ABSTRACT  

Meta-Analysis of Placebo Rates in Major Depressive Disorder Trials
Stolk et al.
The Annals of Pharmacotherapy 2003;37:1891-1899.
ABSTRACT | FULL TEXT  

Integration of Care: Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders
Jindal and Thase
Psychiatr. Serv. 2003;54:1484-1490.
ABSTRACT | FULL TEXT  

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents
Olfson et al.
Arch Gen Psychiatry 2003;60:978-982.
ABSTRACT | FULL TEXT  

Antidepressant prescribing and suicide: Antidepressants do not reduce suicide rates
Ankarberg
BMJ 2003;327:288-289.
FULL TEXT  

Burdens and Benefits of Placebos in Antidepressant Clinical Trials: A Decision and Cost-Effectiveness Analysis
Kim and Holloway
Am. J. Psychiatry 2003;160:1272-1276.
ABSTRACT | FULL TEXT  

Interface between authorship, industry and science in the domain of therapeutics
HEALY and CATTELL
Br. J. Psychiatry 2003;183:22-27.
ABSTRACT | FULL TEXT  

Suicide Rates in Clinical Trials of SSRIs, Other Antidepressants, and Placebo: Analysis of FDA Reports
Khan et al.
Am. J. Psychiatry 2003;160:790-792.
ABSTRACT | FULL TEXT  

Suicide Risk in Placebo vs Active Treatment in Placebo-Controlled Trials for Schizophrenia
Storosum et al.
Arch Gen Psychiatry 2003;60:365-368.
ABSTRACT | FULL TEXT  

Continued Need for Placebo in Many Cases, Even When There Is Effective Therapy
Temple and Meyer
Arch Intern Med 2003;163:371-371.
FULL TEXT  

Injuries among older adults: the challenge of optimizing safety and minimizing unintended consequences
Binder
Inj. Prev. 2002;8:iv2-4.
ABSTRACT | FULL TEXT  

Adequacy of Antidepressant Treatment After Discharge and the Occurrence of Suicidal Acts in Major Depression: A Prospective Study
Oquendo et al.
Am. J. Psychiatry 2002;159:1746-1751.
ABSTRACT | FULL TEXT  

St John's Wort and Depression
Jonas et al.
JAMA 2002;288:446-449.
FULL TEXT  

Role of Antidepressants in Murder and Suicide
TARDIFF et al.
Am. J. Psychiatry 2002;159:1248-1249.
FULL TEXT  

SSRIs and deliberate self-harm * Response from Pfizer * Response from GlaxoSmithKline
Healy et al.
Br. J. Psychiatry 2002;180:547-548.
FULL TEXT  

The Functional Neuroanatomy of the Placebo Effect
Mayberg et al.
Am. J. Psychiatry 2002;159:728-737.
ABSTRACT | FULL TEXT  

Bipolar affective disorder
Verberne and Morriss
BMJ 2002;324:976-976.
FULL TEXT  

Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder: A Randomized Controlled Trial
Hypericum Depression Trial Study Group
JAMA 2002;287:1807-1814.
ABSTRACT | FULL TEXT  

Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh et al.
JAMA 2002;287:1840-1847.
ABSTRACT | FULL TEXT  

National Depressive and Manic-Depressive Association Consensus Statement on the Use of Placebo in Clinical Trials of Mood Disorders
Charney et al.
Arch Gen Psychiatry 2002;59:262-270.
ABSTRACT | FULL TEXT  

The Ethics of Placebo-Controlled Trials -- A Middle Ground
Emanuel and Miller
NEJM 2001;345:915-919.
FULL TEXT  

Symptom Reduction and Suicide Risk Among Patients Treated With Placebo in Antipsychotic Clinical Trials: An Analysis of the Food and Drug Administration Database
Khan et al.
Am. J. Psychiatry 2001;158:1449-1454.
ABSTRACT | FULL TEXT  

Suicide Risk in Placebo-Controlled Studies of Major Depression
Storosum et al.
Am. J. Psychiatry 2001;158:1271-1275.
ABSTRACT | FULL TEXT  

Neuroimaging Profiles and the Differential Therapies of Depression
Thase
Arch Gen Psychiatry 2001;58:651-653.
FULL TEXT  

Placebo response in depression: bane of research, boon to therapy
ANDREWS
Br. J. Psychiatry 2001;178:192-194.
FULL TEXT  

The Changing Role of Dynamic Psychotherapy in Psychiatric Practice
Chodoff
Psychiatr. Serv. 2000;51:1404-1407.
ABSTRACT | FULL TEXT  

Nefazodone, Psychotherapy, and Their Combination for Chronic Depression
Rubin et al.
NEJM 2000;343:1041-1043.
FULL TEXT  

Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases
Ellenberg and Temple
ANN INTERN MED 2000;133:464-470.
ABSTRACT | FULL TEXT  

Placebo Controls: No News Is Good News
Leber
Arch Gen Psychiatry 2000;57:319-320.
FULL TEXT  

The Placebo Problem Remains
Michels
Arch Gen Psychiatry 2000;57:321-322.
FULL TEXT  

What Conditions Are Necessary to Assess Antidepressant Efficacy?
Quitkin and Klein
Arch Gen Psychiatry 2000;57:323-324.
FULL TEXT  

Suicide and Antidepressant Treatment
Hirschfeld
Arch Gen Psychiatry 2000;57:325-326.
FULL TEXT  

Statistical Analysis to Settle Ethical Issues?
Kraemer
Arch Gen Psychiatry 2000;57:327-328.
FULL TEXT  

Placebo Protects Subjects From Nonresponse: A Paradox of Power
Leon
Arch Gen Psychiatry 2000;57:329-330.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.